Literature DB >> 32277300

Botulinum Neurotoxins: Mechanism of Action.

O Rossetto1, M Pirazzini1, F Fabris1, C Montecucco2,3.   

Abstract

Botulinum neurotoxins (BoNTs) are a growing family of bacterial protein toxins that cause botulism, a rare but often fatal animal and human disease. They are the most potent toxins known owing to their molecular architecture, which underlies their mechanism of action. BoNTs target peripheral nerve terminals by a unique mode of binding and enter into their cytosol where they cleave SNARE proteins, thus inhibiting the neurotransmitter release. The specificity and rapidity of binding, which limits the anatomical area of its neuroparalytic action, and its reversible action make BoNT a valuable pharmaceutical to treat neurological and non-neurological diseases determined by hyperactivity of cholinergic nerve terminals. This review reports the progress on our understanding of how BoNTs cause nerve paralysis highlighting the different steps of their molecular mechanism of action as key aspects to explain their extreme toxicity but also their unique pharmacological properties.

Entities:  

Keywords:  Botulinum neurotoxins; Botulism; Neuromuscular junction; Neuroparalysis

Year:  2021        PMID: 32277300     DOI: 10.1007/164_2020_355

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  51 in total

1.  Biosecurity. Panel selects most dangerous select agents.

Authors:  Yudhijit Bhattacharjee
Journal:  Science       Date:  2011-06-24       Impact factor: 47.728

2.  Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Authors:  Cesare Colasante; Ornella Rossetto; Laura Morbiato; Marco Pirazzini; Jordi Molgó; Cesare Montecucco
Journal:  Mol Neurobiol       Date:  2013-03-08       Impact factor: 5.590

Review 3.  Botulinum toxin as a biological weapon: medical and public health management.

Authors:  S S Arnon; R Schechter; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; J Hauer; M Layton; S Lillibridge; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; D L Swerdlow; K Tonat
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

Review 4.  Discovery of novel bacterial toxins by genomics and computational biology.

Authors:  Andrew C Doxey; Michael J Mansfield; Cesare Montecucco
Journal:  Toxicon       Date:  2018-02-10       Impact factor: 3.033

Review 5.  The Synaptic Vesicle Cycle Revisited: New Insights into the Modes and Mechanisms.

Authors:  Natali L Chanaday; Michael A Cousin; Ira Milosevic; Shigeki Watanabe; Jennifer R Morgan
Journal:  J Neurosci       Date:  2019-10-16       Impact factor: 6.167

6.  Long-distance retrograde effects of botulinum neurotoxin A.

Authors:  Flavia Antonucci; Chiara Rossi; Laura Gianfranceschi; Ornella Rossetto; Matteo Caleo
Journal:  J Neurosci       Date:  2008-04-02       Impact factor: 6.167

7.  Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg.

Authors:  Luca Carli; Cesare Montecucco; Ornella Rossetto
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

Review 8.  Botulinum and Tetanus Neurotoxins.

Authors:  Min Dong; Geoffrey Masuyer; Pål Stenmark
Journal:  Annu Rev Biochem       Date:  2018-11-02       Impact factor: 23.643

Review 9.  Receptor and substrate interactions of clostridial neurotoxins.

Authors:  Axel T Brunger; Andreas Rummel
Journal:  Toxicon       Date:  2009-03-04       Impact factor: 3.033

10.  Exploring the Evolution of Virulence Factors through Bioinformatic Data Mining.

Authors:  Andrew C Doxey; Michael J Mansfield; Briallen Lobb
Journal:  mSystems       Date:  2019-05-21       Impact factor: 6.496

View more
  4 in total

Review 1.  Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury.

Authors:  Michael Adler; Sabine Pellett; Shashi K Sharma; Frank J Lebeda; Zygmunt F Dembek; Mark A Mahan
Journal:  Microorganisms       Date:  2022-04-24

Review 2.  Botulinum Toxin in Movement Disorders: An Update.

Authors:  Charenya Anandan; Joseph Jankovic
Journal:  Toxins (Basel)       Date:  2021-01-08       Impact factor: 4.546

3.  Botulinum Neurotoxin Chimeras Suppress Stimulation by Capsaicin of Rat Trigeminal Sensory Neurons In Vivo and In Vitro.

Authors:  Caren Antoniazzi; Mariia Belinskaia; Tomas Zurawski; Seshu Kumar Kaza; J Oliver Dolly; Gary W Lawrence
Journal:  Toxins (Basel)       Date:  2022-02-04       Impact factor: 4.546

4.  Novel Putative Transposable Element Associated with the Subtype E5 Botulinum Toxin Gene Cluster of Neurotoxigenic Clostridium butyricum Type E Strains from China.

Authors:  Tao Li; Nianzhi Ning; Angelo Iacobino; Liangyan Zhang; Hui Wang; Giovanna Franciosa
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.